טוען...
A High-throughput Pharmacoviral Approach Identifies Novel Oncolytic Virus Sensitizers
Oncolytic viruses (OVs) are promising anticancer agents but like other cancer monotherapies, the genetic heterogeneity of human malignancies can lead to treatment resistance. We used a virus/cell-based assay to screen diverse chemical libraries to identify small molecules that could act in synergy w...
שמור ב:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Nature Publishing Group
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2889739/ https://ncbi.nlm.nih.gov/pubmed/20389287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2010.67 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|